OJGas  Vol.3 No.3 , July 2013
Prevalence of HBs Ag among blood donors in Transfusion Center, Abidjan (Ivory Coast)
ABSTRACT
Aim: To study the prevalence of HBsAg among persons without risk factors for hepatitis B. Patients and Methods: Cross-sectional study (28 January to 31 December 2010) about 4310 new volunteers blood donors consecutively recruited. Among all, a risk factor for hepatitis B was investigated (standardized questionnaire and clinical examination). Blood of all blood donors without risk factors of hepatitis B (n = 3823) were systematically collected for HBsAg, hepatitis C antibody, syphilis serology and human immunodeficiency virus serology. The blood was analyzed with a third generation ELISA (Abbott Murex). Results: HBsAg was positive in 179 persons (4.68% [95% CI 4% - 5%]). It was associated with hepatitis C antibodies (0.28% (n = 11)), syphilis antibodies (0.68% (n = 26)) or anti-human immunodeficiency virus antibodies (0.2% (n = 8)). In multivariate analysis, age 30 to 39 years (1.545 [95% CI 1.074 to 2.222]), male sex (2.426 [95% CI 1.550 to 3.799]) and positive syphilis serology (14.344 [95% CI 5.161 to 39.865]) were associated with presence of HBsAg. Conclusion: The prevalence of HBsAg among adult without risk factors for hepatitis B was not negligible. Also, it is essential to maintain routine screening before any vaccination against hepatitis B in adult. Our study is not for an immunization against hepatitis B only targeting risk populations in adult.

Cite this paper
N’dri, N. , Thot’o, A. , Okon, A. , Assi, C. , Allah-Kouadio, E. , Soro, D. , Diakité, M. , Koné, A. , Koné, S. , Lohouès-Kouacou, M. and Camara, B. (2013) Prevalence of HBs Ag among blood donors in Transfusion Center, Abidjan (Ivory Coast). Open Journal of Gastroenterology, 3, 165-169. doi: 10.4236/ojgas.2013.33027.
References
[1]   Rouet, F., Chaix, M.L., Inwoley, A., Msellati, P., Viho, I., Combe, P., et al. (2004) HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote-d’Ivoire: The ANRS 1236 study. Journal of Medical Virologie, 74, 34-40. doi:10.1002/jmv.20143

[2]   Kra, O., N’Dri, N., Ehui, E., Ouattara, B. and Bissagnene, E. (2007) Prevalence of HBsAg among blood donors in regional blood transfusion center in Bouaké (Cote d’Ivoire) in 2001. Bulletin de la Société de Pathologie Exotique, 100, 127-129.

[3]   Assi, C., Allah-Kouadio, E., Ouattara, A., Diakité, M., Koné, S., Lohouès-Kouacou, M.J., et al. (2011) Vaccination coverage against the hepatitis B and prevalence of HBsAg: Cross-sectional study of 592 persons in Abidjan. Clinics and Research in Hepatology and Gastroenterology, 35, 506-507. doi:10.1016/j.clinre.2011.02.010

[4]   Magoni, M., Ekra, K.D., Aka, L.N., Sita, K.S. and Kanga, K. (2009) Effectiveness of hepatitis-B vaccination in Ivory Coast: The case of the Grand-Bassam health district. Annals of Tropical Medicine and Parasitology, 103, 519527. doi:10.1179/136485909X451816

[5]   Poland, G.A. and Jacobson, R.M. (2004) Clinical practice: Prevention of hepatitis B with the hepatitis B Vaccine. New England Journal of Medicine, 351, 2832-2838. doi:10.1056/NEJMcp041507

[6]   Matee, M.I.N., Magesa, P.M. and Lyamuya, E.F. (2006) Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. Biomedical Central Public Health, 6, 21-26. doi:10.1186/1471-2458-6-21

[7]   Mbanya, D.N., Takam, D. and Ndumbe, P.M. (2003) Serological findings amongst first-time blood donors in Yaoundé, Cameroon: Is safe donation a reality or a myth? Transfusion Medicine, 13, 267-273. doi:10.1046/j.1365-3148.2003.00453.x

[8]   Loua, A., Diallo, M.B., Agassouba, F.B.M., Camara, M., Bah, M.A. and Cisse, A. (2005) Seroprevalence of heaptitis B among blood donors in Guinea. Médecine Tropicale, 65, 396-397.

[9]   Dray, X., Dray-Spira, R., Bronstein, J.A. and Mattera, D. (2005) [Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti]. Médecine Tropicale, 65, 39-42.

[10]   Batina, A., Kabemba, S. and Malengela, R. (2007) Infectious markers among blood donors in Democratic Republic of Congo (DRC). Revue Médicale de Bruxelle, 28, 145-149.

[11]   Buseri, F.I., Muhibi, M.A. and Jeremiah, Z.A. (2009) Seroepidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. Blood Transfusion, 7, 293-299.

[12]   Diarra, A., Kouriba, B., Baby, M., Murphy, E. and Lefrere, J.J. (2009) HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: Lower rates among volunteer blood donors. Transfusion Clinique et Biologique, 16, 444-447. doi:10.1016/j.tracli.2009.09.004

[13]   Mogtomo, M.L., Fomekong, S.L., Kuate, H.F. and Ngane, A.N. (2009) Screening of infectious microorganisms in blood banks in Douala (1995-2004). Santé, 19, 3-8.

[14]   Nagalo, M.B., Sanou, M., Bisseye, C., Kaboré, M.I., Nebie, Y.K., Kienou, K., et al. (2011) Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfusion, 9, 419-424.

[15]   Tounkara, A., Sarro, Y.S., Kristensen, S., Dao, S., Diallo, H., Diarra, B., et al. (2009) Seroprevalence of HIV/HBV coinfection in Malian blood donors. Journal of the International Association of Physicians in AIDS Care (Chic), 8, 47-51. doi:10.1177/1545109708330118

[16]   Touré-Fall, A.O., Dièye, T.N., Sall, A., Diop, M., Seck, M., Diop, S., et al. (2009) Residual risk of transmission of HIV and HBV, in Senegalese national blood bank from 2003 to 2005. Transfusion Clinique et Biologique, 16, 439-443. doi:10.1016/j.tracli.2009.09.005

[17]   Adekanle, O., Ndububa, D.A., Ayodeji, O.O., Paul-Odo, B. and Folorunso, T.A. (2010) Sexual transmission of the hepatitis B virus among blood donors in a tertiary hospital in Nigeria. Singapore Medical Journal, 51, 944-947.

[18]   Allain, J.P., Candotti, D., Soldan, K., Sarkodie, F., Phelps, B., Giachetti, C., Shyamala, V., et al. (2003) The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood, 101, 2419-2425. doi:10.1182/blood-2002-04-1084

[19]   Stokx, J., Gillet, P., De Weggheleire, A., Casas, E.C., Maendaenda, R., Beulane, A.J., et al. (2011) Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. BMC Infectious Diseases, 23, 111-141.

[20]   Dongdem, J.T., Kampo, S., Soyiri, I.N., Asebga, P.N. and Ziem, J.B. (2012) Prevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana (2009). BMC Research Notes, 5, 115-126. doi:10.1186/1756-0500-5-115

[21]   Tagny, C.T., Diarra, A., Yahaya, R., Hakizimana, M., Nguessan, A., Mbensa, G., et al. (2009) Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion, 49, 1592-1599. doi:10.1111/j.1537-2995.2009.02137.x

[22]   Arivelo, R.Z., Hendrison, R.D., Elie, R.M.F., Tantely, R.M., Ramamonjisoa, A., Barnia, R.F., et al. (2011) The seroprevalence of hepatitis B surface antigen among first time blood donors in Antananarivo (Madagascar) from 2003 to 2009. Blood Transfusion, 9, 475-477.

[23]   Eissa, S.A., Abdel Meguid, L.M., Ebeid, S.M., Abou Elfetouh, R.M. and Abdel Moneim, G.M. (2007) National Cancer Institute Experience in Healthy Egyptian Blood Donors as Regards Blood Group Frequencies and Seroprevalence of Hepatitis B Virus, Hepatitis C Virus & HIV: 10 Year Evaluation. Journal of the Egyptian National Cancer Institute, 19, 71-76.

[24]   Wasfi, O.A. and Sadek, N.A. (2011) Prevalence of heaptitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. Eastern Mediterranean Health Journal, 17, 238-242.

[25]   Zohoun, A., Hadef, R., Zahid, H. and Benkirane, M. (2011) Seroprevalence of HBV and HCV in blood donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco. Medecine Tropicale, 71, 513-514.

[26]   Meena, M., Jindal, T. and Hazarika, A. (2011) Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: A five-year study. Transfusion, 51, 198-202. doi:10.1111/j.1537-2995.2010.02801.x

[27]   O’Brien, S.F., Xi, G., Fan, W., Yi, Q.L., Fearon, M.A., Scalia, V. and Goldman, M. (2008) Epidemiology of hepatictis B in Canadian blood donors. Transfusion, 48, 23232330. doi:10.1111/j.1537-2995.2008.01845.x

[28]   Lohouès-Kouacou, M.J., Touré, M., Hillah, J., Camara, B.M., Ndri, N., Kouamé, K.J., et al. (1998) Materno-foetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination. Santé, 8, 401-404.

[29]   Jeremiah, Z.A., Koate, B., Buseri, F. and Emelike, F. (2008) Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt blood donors and association with blood groups and other risk indicators. Blood Transfusion, 6, 150-155.

[30]   Umolu, P.I., Okoror, L.E. and Orhue, P. (2005) Human immunodeficiency virus (HIV) seropositivity and hepatictis B surface antigenemia (HBSAG) among blood donors in Benin City, Edo state, Nigeria. African Health Sciences, 5, 55-58.

 
 
Top